Langerhans cell histiocytosis treated with narrow-band ultraviolet B

Journal of Dermatology

Volumn 38, Issue 2, 2011, Pages 151-154

  Aihara, Michiko ^a   Hasegawa, Toshio ^a   Okuyama, Yasuhiro ^a   Hiruma, Masataro ^a   Ikeda, Shigaku ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Langerhans cell histiocytosis; narrow band ultraviolet B; psoralen and ultraviolet A therapy

Indexed keywords

PSORALEN;

ABDOMINAL TUMOR; ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; ERYTHEMA; HISTIOCYTOSIS; HUMAN; IRRADIATION; LANGERHANS CELL; MALE; PIGMENTATION; PUVA; RADIATION DOSE; ULTRAVIOLET B RADIATION;

HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MALE; MIDDLE AGED; SKIN DISEASES; TREATMENT OUTCOME; ULTRAVIOLET RAYS; ULTRAVIOLET THERAPY;

EID: 79251589373     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.00959.x     Document Type: Article

References (21)

1. Lichtenstein L,. Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schuller-Christian disease as related manifestations of a single nosologic entity. AMA Arch Pathol 1953; 56: 84-102.
2. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet 1987; 1: 208-209.
3. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ,. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Cancer 1999; 85: 2278-2290.
4. Iwatsuki K, Tsugiri M, Yoshizawa N, Takigawa M, Yamada M, Shamoto M,. The effect of phototherapies on cutaneous lesions of histiocytosis X in the elderly. Cancer 1986; 57: 1931-1936.
5. Sakai H, Ibe M, Takahashi H, et al. Satisfactory remission achieved by PUVA therapy in Langerhans cell histiocytosis in an elderly patient. J Dermatol 1996; 23: 42-46.
6. Misery L, Larbre B, Lyonnet S, Faure M, Thivolet J,. Remission of Langerhans cell histiocytosis with thalidomide treatment. Clin Exp Dermatol 1993; 18: 487.
7. Thomas L, Ducros B, Secchi T, Balme B, Moulin G,. Successful treatment of adults Langerhans cell histiocytosis with thalidomide. Report of two cases and literature review. Arch Dermatol 1993; 129: 1261-1264.
8. Tsambaos D, Georgiou S, Kapranos N, Monastirli A, Stratigos A, Berger H,. Langerhans cell histiocytosis: complete remission after oral isotretinoin therapy. Acta Dermatol Venereol 1995; 75: 62.
9. El-Mofty M, El-Darouty M, Salonas M, et al. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study. Photodermatol Photoimmunol Photomed 2005; 21: 281-286.
10. Matsuoka Y, Yoneda K, Katsuura J, et al. Successful treatment of follicular cutaneous T-cell lymphoma without mucinosis with narrow-band UVB irradiation. J Eur Acad Dermatol Venereol 2007; 21: 1121-1122.
11. Brazzelli V, Antoninetti M, Palazzini S, Prestinari F, Borroni G,. Narrow-band ultraviolet therapy in early-stage mycosis fungoides: study on 20 patients. Photodermatol Photoimmunol Photomed 2007; 23: 229-233.
12. Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A,. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol 2005; 52: 660-670.
13. Duthie MS, Kimber I, Norval M,. The effects of ultraviolet radiation on the human immune system. Br J Dermatol 1999; 140: 995-1009.
14. Matsumura Y, Ananthaswamy HN,. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 2004; 195: 298-308.
15. El-Ghorr AA, Norval M,. Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol 1997; 38: 99-106.
16. Moodycliffe AM, Kimber I, Norval M,. Role of tumor necrosis factor-alpha in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology 1994; 81: 79-84.
17. Tjioe M, Smits T, van de Kerkhof PC, Gerritsen MJ,. The differential effect of broad band vs narrow band UVB with respect to photodamage and cutaneous inflammation. Exp Dermatol 2003; 12: 729-733.
18. Sigmundsdottir H, Johnson A, Gudjonsson JE, Valdimarsson H,. Narrowband-UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells. Arch Dermatol Res 2005; 297: 39-42.
19. Young A,. Cercinogenicity of UVB phototherapy assessed. Lancet 1995; 345: 1431-1432.
20. Man I, Crombie IK, Dawe RS, Ibbotson SH, Ferguson J,. The photocarcinogenic risk of narrow-band UVB (TL-01) phototherapy: early follow-up data. Br J Dermatol 2005; 152: 755-757.
21. Black RJ, Gavin AT,. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data. Br J Dermatol 2006; 154: 566-567.